@article{ref1,
title="Feasibility and safety of Robot Suit HAL treatment for adolescents and adults with cerebral palsy",
journal="Journal of clinical neuroscience",
year="2019",
author="Ueno, Tomoyuki and Watanabe, Hiroki and Kawamoto, Hiroaki and Shimizu, Yukiyo and Endo, Ayumu and Shimizu, Tomoe and Ishikawa, Kimihisa and Kadone, Hideki and Ohto, Tatsuyuki and Kamada, Hiroshi and Marushima, Aiki and Hada, Yasushi and Muroi, Ai and Sankai, Yoshiyuki and Ishikawa, Eiichi and Matsumura, Akira and Yamazaki, Masashi",
volume="ePub",
number="ePub",
pages="ePub-ePub",
abstract="To investigate whether Robot Suit HAL treatment (HAL-T) is safe and feasible for gait disorders in adolescents and adults with cerebral palsy (CP). We tested HAL-T in adolescents and adults with bilateral spastic CP (four men, four women; mean age: 18.2 years). Three participants were classified as level III under the Gross Motor Function Classification System (GMFCS), and five were classified as level IV. The participants underwent HAL-T twice per week for 4 weeks. The outcome measures, which were assessed before and after HAL-T, included comfortable gait speed (CGS), step length (SL), cadence, and GMFCS level. Adverse events were noted. All participants completed the HAL-T sessions despite some mild adverse events occurring. The mean increases in CGS, SL, and cadence were 0.19 ± 0.14 m/s (p = 0.006), 0.09 ± 0.08 m (p = 0.020), and 18.0 ± 15.9 steps/min (p = 0.015), respectively. HAL-T is safe and feasible for gait disorders in patients with CP. HAL-T can significantly improve CGS, SL, and cadence and may be effective for improving walking ability in adolescents and adults with CP.<br><br>Copyright © 2019 Elsevier Ltd. All rights reserved.<p /> <p>Language: en</p>",
language="en",
issn="0967-5868",
doi="10.1016/j.jocn.2019.07.026",
url="http://dx.doi.org/10.1016/j.jocn.2019.07.026"
}